E. Noviello

Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines

S. Parodi, P. Russo, P. Conte, 1992, Japanese journal of cancer research : Gann.

Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.

N. Ragni, F. Barbieri, A. Alama, 1996, Gynecologic oncology.

Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation

S. Parodi, P. Russo, P. Conte, 1992, Japanese journal of cancer research : Gann.

“Atypical” multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3)

S. Parodi, M. Valenti, P. Russo, 2005, Journal of Cancer Research and Clinical Oncology.

Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.

S. Parodi, P. Russo, M. Aluigi, 1994, Mutation research.

In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice

A. Villa, M. Zoppè, P. Vezzoni, 1998, Gene Therapy.